Skip to main content
Clinical Trials/NCT06197360
NCT06197360
Completed
Not Applicable

Effects of a Health Education Intervention Based on the Behaviour Change Wheel on Fear of Hypoglycemia in Patients With Type 2 Diabetes Mellitus: a Pilot Study

Yangzhou University1 site in 1 country50 target enrollmentAugust 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Type 2 Diabetes Mellitus
Sponsor
Yangzhou University
Enrollment
50
Locations
1
Primary Endpoint
Hypoglycemia Fear Behavioral
Status
Completed
Last Updated
last year

Overview

Brief Summary

The purpose of this study was to construct a Fear of Hypoglycemia(FoH) intervention program for type 2 diabetic patients based on the Behaviour Change Wheel (BCW) theory and to investigate the feasibility, acceptability, and initial effects of the program.

Detailed Description

In this study, eligible participants were randomized in a 1:1 ratio into an intervention group (health education based on BCW theory given on top of regular diabetes health education) and a control group (regular diabetes health education), with a 4-week intervention period and a 4-week follow-up period, for a total of 8 weeks.

Registry
clinicaltrials.gov
Start Date
August 1, 2021
End Date
January 31, 2022
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Yangzhou University
Responsible Party
Principal Investigator
Principal Investigator

Zhao Yueqi

Principal Investigator

Yangzhou University

Eligibility Criteria

Inclusion Criteria

  • Comply with the 2020 Chinese guidelines for the prevention and treatment of type 2 diabetes mellitus
  • Age ≥18 years
  • Duration of diabetes mellitus ≥1 year
  • FOH according to the elevated item endorsement criterion (E I criterion): ≥3 points on any item of the Hypoglycemic Fear-Worry Scale (HFS-WS)
  • Patients who have the ability to listen, read, write, walk, and cooperate to complete the study
  • Patients who have a smart phone, and can skillfully use WeChat or telephone to communicate
  • Voluntarily participate in this study and sign the informed consent form.

Exclusion Criteria

  • Patients with comorbid acute complications or other serious diseases or disorders of consciousness, such as diabetic hypertonic state, tumors, coma, etc.
  • Patients with comorbid psychiatric diseases or taking psychotropic drugs
  • Patients who have recently or are participating in other studies on similar topics

Outcomes

Primary Outcomes

Hypoglycemia Fear Behavioral

Time Frame: Baseline, immediately after the intervention and after the 4 weeks follow-up

Hypoglycemia Fear Survey - Behavior Scale consists of 19 entries and is scored on a 5-point Likert scale from 1 to 5, with total scores ranging from 15 (lowest) to 95 (highest), with the higher scores indicating that the patients' hypoglycemia fear-behavior is more pronounced, and the higher the level of fear of hypoglycemia.

Hypoglycemia Fear Worry

Time Frame: Baseline, immediately after the intervention and after the 4 weeks follow-up

Hypoglycemic fear Survey - Worry Scale was used to evaluate the patients' hypoglycemic feelings in the past 6 months. There were 13 items in the scale, using 5-point Likert scale, with scores ranging from low to high 0-4, and the total score ranging from 0 (lowest) to 52 (highest). The higher the score, the higher the patient's fear of hypoglycemia.

Secondary Outcomes

  • The Patients Assessment Chronic Illness Care( PACIC)(Baseline, immediately after the intervention and after the 4 weeks follow-up)
  • Gold Rating(Baseline, immediately after the intervention and after the 4 weeks follow-up)
  • The Self-management Attitude Scale for Diabetes Patients(Baseline, immediately after the intervention and after the 4 weeks follow-up)

Study Sites (1)

Loading locations...

Similar Trials